The healthcare industry is currently navigating a period of unprecedented financial and operational strain, characterized by rising labor costs, an aging population, and a transition toward value-based care models. In response to these challenges, League, a leading healthcare platform-as-a-service provider, has released a comprehensive white paper detailing how pioneering healthcare organizations are leveraging innovative technology […]
Processa Pharmaceuticals has announced a definitive agreement to acquire Vidya Therapeutics in an all-stock transaction, signaling a wholesale strategic pivot toward the high-growth immunology and inflammation market. Concurrent with the acquisition, the Vero Beach, Florida-based biotechnology firm has secured approximately $200 million in a private placement from a consortium of elite life sciences investors. The […]
Doctronic, a prominent New York City-based artificial intelligence healthcare firm, has officially announced its expansion into the pediatric sector through the strategic acquisition of Summer Health, a leading virtual pediatric care provider. This move marks a significant milestone in Doctronic’s mission to establish the first fully integrated, AI-native primary care platform capable of serving every […]
The Centers for Medicare & Medicaid Services (CMS) has officially introduced its 2025 Interoperability Framework, marking a pivotal transition in the federal government’s approach to national health data exchange. Moving away from the rigid mandates that characterized previous decades, the 2025 framework is presented as a collaborative blueprint designed to unify Electronic Medical Record (EMR) […]
Altimmune, a clinical-stage biopharmaceutical company based in Gaithersburg, Maryland, has announced positive topline results from its Phase 2 RECLAIM clinical trial evaluating pemvidutide for the treatment of alcohol use disorder (AUD). The data, released on Tuesday, indicate that the investigational drug, a dual agonist of the glucagon-like peptide-1 (GLP-1) and glucagon receptors, successfully met its […]
Included Health, a prominent provider of healthcare navigation and virtual care services, announced on Tuesday a definitive agreement to acquire Firefly Health, a Massachusetts-based primary care and health plan provider, in a move designed to accelerate the delivery of comprehensive, primary-care-led health insurance alternatives for employers. The acquisition represents a significant consolidation in the digital […]
Throne Science, a health-technology startup headquartered in Austin, Texas, has successfully closed a $10 million Series A funding round to accelerate the development and distribution of its innovative AI-integrated toilet sensor. The funding round, led by Will Ventures, brings the company’s total capital raised to nearly $18 million. Other notable participants in the round include […]
The healthcare insurance landscape is currently undergoing a significant strategic realignment as payers navigate the complexities of Utilization Management (UM) and Case Management (CM). A growing consensus among industry leaders suggests a hybrid approach to medical necessity reviews: moving routine, high-volume UM tasks in-house while delegating complex, high-stakes specialty care—particularly Neonatal Intensive Care Unit (NICU) […]
The United States healthcare system is approaching a critical juncture that threatens the fundamental safety and efficacy of inpatient care. According to a 2025 study published in JAMA Network Open, average hospital occupancy rates in the U.S. have surged to 75%, representing a significant 11-percentage-point increase from the pre-pandemic baseline of approximately 64%. If current […]
The Dutch biotechnology giant Argenx has officially announced a definitive agreement to acquire Forte Biosciences for approximately $2.2 billion, marking a significant strategic pivot from its established focus on rare diseases toward more prevalent autoimmune conditions. The deal, which represents Argenx’s first major acquisition, centers on the integration of FB102, a first-in-class monoclonal antibody targeting […]
